Index > Vol. 89/2009 > Iss. 3/May > pp. 267-270 > Abstract
Investigative Report | Hair, Psychodermatology and quality of life

Frequency and Treatment of Trichotillomania in Poland

doi: 10.2340/00015555-0630

Abstract:

Although trichotillomania is a relatively common disorder no large epidemiological studies are available. The aims of this study were to determine the frequency of trichotillomania as identified by Polish dermatologists, and to evaluate the treatment modalities used. A questionnaire was sent to 172 dermatologists; 118 (68.6%) responded. The questions covered demographic data, frequency of trichotillomania and treatments used. During the course of their working lives 68% of respondents had observed at least one patient with trichotillomania and 11% were currently treating such a patient. More than 30% of respondents had observed one or two cases of trichotillomania during the past 5 years, 11% had seen 3–5 cases, 3% had seen 6–10 cases, and 5% had seen more than 10 patients. Of the respondents, 40.7% always and 28.8% often asked for a psychiatric opinion. Dermatologists with more experience more frequently (p < 0.05) obtained a psychiatric opinion. Some dermatologists (15.3%) used their own pharmacological treatment
(anxiety-relieving drugs and sedatives). Trichotillomania is a relatively common disorder; however, not all dermatologists are sufficiently prepared to treat it.

Authors:

Jacek C. Szepietowski, Joanna Salomon, Przemysław Pacan, Ewa Hrehorów and Anna Zalewska

Key words:

trichotillomania; hair loss; frequency; treatment modalities; dermatological practice.

References

  1. Sah DE, Koo J, Price VH. Trichotillomania. Dermatol Ther 2008; 21: 13–21. Link to article
  2. O’Sullivan RL, Rauch SL, Breiter HC, Grachev ID, Baer L, Kennedy DN, et al. Reduced basal ganglia volumes in trichotillomania measured via morphometric magnetic resonance imaging. Biol Psychiatry 1997; 42: 39–45. Link to article
  3. Cohen LJ, Stein DJ, Simeon D, Spadaccini E, Rosen J, Aronowitz B, et al. Clinical profile, comorbidity, and treatment history in 123 hair pullers: a survey study. J Clin Psychiatry 1995; 56: 319–326.
  4. Papadopoulos AJ, Janniger CK, Chodynicki MP, Schwartz RA. Trichotillomania. Int J Dermatol 2003; 42: 330–334.
  5. Oguchi T, Miura S. Trichotillomania: its psychopathological aspect. Compr Psychiatry 1977; 18: 177–182. Link to article
  6. Walsh KH, McDougle CJ. Trichotillomania. Presentation, etiology, diagnosis and therapy. Am J Clin Dermatol 2001; 2: 327–333. Link to article
  7. Christenson GA, Mackenzie TB, Mitchell JE. Characteristics of 60 adult chronic hair pullers. Am J Psychiatry 1991; 148: 365–370.
  8. Schneider D, Janniger CK. Trichotillomania. Cutis 1994; 53: 289–294.
  9. King RA, Zohar AH, Ratzoni G, Binder M, Kron S, Dycian A, et al. An epidemiological study of trichotillomania in Israeli adolescents. J Am Acad Child Adolesc Psychiatry 1995; 34: 1212–1215.
  10. Schlosser S, Black DW, Blum N. The demography, phenomenology and family history of 22 persons with compulsive hair pulling. Ann Clin Psychiatry 1994; 6: 147–152. Link to article
  11. Hautmann G, Hercogova J, Lotti T. Trichotillomania. J Am Acad Dermatol 2002; 46: 807–821.
  12. Mehregan AH. Trichotillomania. A clinicopathologic study. Arch Dermatol 1970; 102: 129–133. Link to article
  13. Szepietowski J, Pacan P, ‰öwiebocka D. Atypical clinical manifestation of trichotillomania. Przegl Dermatol 2002; 89: 219–221.
  14. Christenson GA, Crow SJ. The characterization and treatment of trichotillomania. J Clin Psychiatry 1996; 57: 42–49.
  15. Murphy C, Redenius R, O’Neill E, Zallek S. Sleep-isolated trichotillomania: a survey of dermatologists. J Clin Sleep Med 2007; 15: 719–721.
  16. Rothbaum BO, Shaw L, Morris R. Prevalence of trichotillomania in a college freshman population. J Clin Psychiatry 1993; 54: 71.
  17. Reeve E. Hair pulling in children and adolescents. In: Stein DJ, Christenson GA, Hollander E, editors. Trichotillomania. Washington, DC: American Psychiatric Press Inc., 1999: p. 201–224.
  18. Keuthen NJ, O’Sullivan RI, Goodchild P, Rodriguez D, Jenike MA, Baer L. Retrospective review of treatment outcome for 63 patients with trichotillomania. Am J Psychiatry 1998; 155: 560–561.
  19. Bruce TO, Barwick LW, Wright HH. Diagnosis and management of trichotillomania in children and adolescents. Pediatr Drugs 2005; 7: 365–376. Link to article
  20. Marcks BA, Wetterneck CT, Woods DW. Investigating healthcare providers’ knowledge of trichotillomania and its treatment. Cogn Behav Ther 2006; 35: 19–27.
  21. Keuthen NJ, O’Sullivan RL, Sprich-Buckminster S. Trichotillomania: current issues in conceptualization and treatment. Psychother Psychosom 1998; 67: 202–213. Link to article
  22. O’Sullivan RL, Keuthen NJ, Christenson GA, Mansueto CS, Stein DJ, Swedo SE. Trichotillomania: behavioral symptom or clinical syndrome? Am J Psychiatry 1997; 154: 1442–1449.
  23. Peterson AL, Campise RL, Azrin NH. Behavioral and pharmacological treatments for tic and habit disorders: a review. J Dev Behav Pediatr 1994; 15: 430–441.
  24. Chamberlain SR, Menzies L, Sahakian BJ. Lifting the veil on trichotillomania. Am J Psychiatry 2007; 164: 568–574. Link to article
  25. Bloch MH, Landeros-Weisenberger A, Dombrowski P, Kelmendi B, Wegner R, Nudel J, et al. Systematic review: pharmacological and behavioral treatment for trichotillomania. Biol Psychiatry 2007; 62: 839–846. Link to article
  26. Thoren P, Asberg M, Cronholm B, Jornestedt L, Traskman L. Clomipramine treatment of obsessive-compulsive disorder. I. A clinical trial. Arch Gen Psychiatry 1980; 37: 1281–1285.
  27. Swedo SE, Leonard HL, Rapoport JL, Lenane MC, Goldberger EL, Cheslow DL. A double-blind comparison of clomipramine and desiparamine in the treatment of trichotillomania (hair pulling). N Eng J Med 1989; 321: 497–501.
  28. Stanley MA, Breckenridge KJ, Swann AC, Freeman EB, Reich L. Fluvoxamine treatment of trichotillomania. J Clin Psychopharm 1997; 17: 278–283. Link to article
  29. Stanley MA, Bowers TC, Swann AC, Taylor DJ. Treatment of trichotillomania with fluoxetine. J Clin Psychiatry 1991; 52: 282.
  30. Block C, West SA, Baharoglu B. Paroxetine treatment of trichotillomania in an adolescent. J Child Adolesc Psychopharm 1998; 8: 69–71.
  31. De Sousa A. An open-label pilot study of naltrexone in childhood-onset trichotillomania. J Child Adolesc Psychopharmacol 2008; 18: 30–33.
  32. Stein DJ, Hollander E. Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania. J Clin Psychiatry 1992; 53: 123–126.
  33. Stein DJ, Bouwer C, Hawkridge S, Emsley RA. Risperidone augmentation of serotonin reuptake inhibitors in obsessive-compulsive and related disorders. J Clin Psychiatry 1997; 58: 119–122.
  34. Van Ameringen M, Mancini C, Oakman JM, Farvolden P. The potential role of haloperidol in the treatment of trichotillomania. J Affect Disord 1999; 56: 219–226.
  35. Szepietowski JC, Salomon J, Hrehorˆ„w E, Pacan P, Zalewska A, Sysa-JŸôdrzejowska A. Delusional parasitosis in dermatological practice. J Eur Acad Dermatol Venereol 2007; 21: 462–465.
  36. Szepietowski JC, Salomon J, Pacan P, Hrehorˆ„w E, Zalewska A. Body dysmorphic disorder and dermatologists. J Eur Acad Dermatol Venereol 2008; 22: 795–799.Link to article